Perturbation of specific pro-mineralizing signalling pathways in human and murine pseudoxanthoma elasticum

Orphanet Journal of Rare Diseases

Olivier M Vanakker²  Anne De Paepe²  Olivier Le Saux¹  Paul J Coucke²  Mohammad J Hosen³ 

[1] Department of Cell and Molecular Biology, John A. Burns School of Medicine, Honolulu, HI, USA;Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;Department of Genetic Engineering and Biotechnology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh

关键词: Endoplasmic reticulum stress;    Apoptosis;    Canonical Wnt pathway;    TGFβ signalling;    BMP2-SMADs-RUNX2;    Osteogenic signalling pathway;    Elastic fibres;    Ectopic mineralization;    Pseudoxanthoma elasticum;   

Others  :  861873
DOI  :  10.1186/1750-1172-9-66

 received in 2013-10-25, accepted in 2014-04-14,  发布年份 2014

【 摘 要 】

Background

Pseudoxanthoma elasticum (PXE) is characterized by skin (papular lesions), ocular (subretinal neovascularisation) and cardiovascular manifestations (peripheral artery disease), due to mineralization and fragmentation of elastic fibres in the extracellular matrix (ECM). Caused by mutations in the ABCC6 gene, the mechanisms underlying this disease remain unknown. The knowledge on the molecular background of soft tissue mineralization largely comes from insights in vascular calcification, with involvement of the osteoinductive Transforming Growth Factor beta (TGFβ) family (TGFβ1-3 and Bone Morphogenetic Proteins [BMP]), together with ectonucleotides (ENPP1), Wnt signalling and a variety of local and systemic calcification inhibitors. In this study, we have investigated the relevance of the signalling pathways described in vascular soft tissue mineralization in the PXE knock-out mouse model and in PXE patients.

Methods

The role of the pro-osteogenic pathways BMP2-SMADs-RUNX2, TGFβ-SMAD2/3 and Wnt-MSX2, apoptosis and ER stress was evaluated using immunohistochemistry, mRNA expression profiling and immune-co-staining in dermal tissues and fibroblast cultures of PXE patients and the eyes and whiskers of the PXE knock-out mouse. Apoptosis was further evaluated by TUNEL staining and siRNA mediated gene knockdown. ALPL activity in PXE fibroblasts was studied using ALPL stains.

Results

We demonstrate the upregulation of the BMP2-SMADs-RUNX2 and TGFβ-2-SMAD2/3 pathway, co-localizing with the mineralization sites, and the involvement of MSX2-canonical Wnt signalling. Further, we show that apoptosis is also involved in PXE with activation of Caspases and BCL-2. In contrast to vascular calcification, neither the other BMPs and TGFβs nor endoplasmic reticulum stress pathways seem to be perturbed in PXE.

Conclusions

Our study shows that we cannot simply extrapolate knowledge on cell signalling in vascular soft tissue calcification to a multisystem ectopic mineralisation disease as PXE. Contrary, we demonstrate a specific set of perturbed signalling pathways in PXE patients and the knock-out mouse model. Based on our findings and previously reported data, we propose a preliminary cell model of ECM calcification in PXE.

【 授权许可】

   
2014 Hosen et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Uitto J, Pulkkinen L, Ringpfeil F: Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface? Trends Mol Med 2001, 7:13-17.
• [2]Uitto J, Jiang Q: Pseudoxanthoma Elasticum-like phenotypes: more diseases than one. J Invest Dermatol 2007, 127:507-510.
• [3]Schinke T, McKee MD, Karsenty G: Extracellular matrix calcification: where is the action? Nat Genet 1999, 21:225-229.
• [4]Wallin R, Wajih N, Greenwood GT, Sane DC: Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 2001, 21:274-301.
• [5]Vanakker OM, Martin L, Schurgers LJ, Quaglino D, Costrop L, Vermeer C, Pasquali-Ronchetti I, Coucke PJ, De Paepe A: Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. Lab Invest 2010, 90:895-905.
• [6]Hendig D, Zarbock R, Szliska C, Kleesiek K, Götting C: The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem 2008, 18:407-412.
• [7]Hendig D, Arndt M, Szliska C, Kleesiek K, Götting C: SPP1 promotor polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin Chem 2007, 53:829-836.
• [8]Contri MB, Boraldi F, Taparelli F, De Paepe A, Ronchetti IP: Matrix proteins with high affinity for calcium are associated with mineralization within the elastic fibres of pseudoxanthoma elasticum dermis. Am J Pathol 1996, 148:569-577.
• [9]Jiang Q, Li Q, Uitto J: Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J Invest Dermatol 2007, 127:1392-1402.
• [10]Stafford DW: The Vitamin K cycle. J Thromb Haemost 2005, 3:1873-1878.
• [11]Sweatt A, Sane DC, Hutson SM, Willin R: Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2002, 1:178-185.
• [12]Wallin R, Cain D, Hutson SM, Sane DC, Loeser R: Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). J Thromb Haemost 2000, 84:1039-1044.
• [13]Zebboudj AF, Shin V, Bostrom K: Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 2003, 90:756-765.
• [14]Towler DA, Shao JS, Cheng SL, Pingsterhaus JM, Loewy AP: Osteogenic regulation of vascular calcification. Ann N Y Acad Sci 2006, 1068:327-333.
• [15]Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, Gotting C: Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 2005, 52:227-234.
• [16]Nitschke Y, Baujat G, Botschen U, Wittkampf T, du Moulin M, Stella J, Le Merrer M, Guest G, Lambot K, Tazarourte-Pinturier MF, Chassaing N, Roche O, Feenstra I, Loechner K, Deshpande C, Garber SJ, Chikarmane R, Steinmann B, Shahinyan T, Martorell L, Davies J, Smith WE, Kahler SG, McCulloch M, Wraige E, Loidi L, Höhne W, Martin L, Hadj-Rabia S, Terkeltaub R, Rutsch F: Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 2012, 90:25-39.
• [17]Li Q, Schumacher W, Jablonski D, Siegel D, Uitto J: Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1. Br J Dermatol 2012, 166:1107-1111.
• [18]Persy V, D’Haese P: Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 2009, 15:405-416.
• [19]Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB: Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 2008, 283:8412-8422.
• [20]Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa 1 and downregulation of smooth muscle lineage markers. Circ Res 2001, 89:1147-1154.
• [21]Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P: TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997, 16:5353-5362.
• [22]Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L: MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996, 86:543-552.
• [23]Zhang Y, Feng X, We R, Derynck R: Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 1996, 383:168-172.
• [24]Abreu JG, Ketpura NI, Reversade B, De Robertis EM: Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002, 4:599-604.
• [25]Qi W, Chen X, Poronnik P, Pollock CA: Transforming growth factor-beta/connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol 2008, 40:9-13.
• [26]Wahab NA, Weston BS, Mason RM: Modulation of the TGFbeta/Smad signalling pathway in mesangial cells by CTGF/CCN2. Exp Cell Res 2005, 307:305-314.
• [27]Jahnen-Dechent W, Heiss A, Schäfer C, Ketteler M: Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011, 108:1494-1509.
• [28]Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM: Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011, 109:697-711.
• [29]Son BK, Kozaki K, Iijima K, Eto M, Nakano T, Akishita M, Ouchi Y: Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol 2007, 556:1-8.
• [30]Collett G, Wood A, Alexander MY, Varnum BC, Boot-Handford RP, Ohanian V, Ohanian J, Fridell YW, Canfield AE: Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res 2003, 92:1123-1129.
• [31]McCarthy TL, Centrella M: Novel links among Wnt and TGF-beta signalling and Runx2. Mol Endocrinol 2010, 24:587-597.
• [32]Holleville N, Matéos S, Bontoux M, Bollerot K, Monsoro-Burq AH: Dlx5 drives Runx2 expression and osteogenic differentiation in developing cranial suture mesenchyme. Dev Biol 2007, 304:860-874.
• [33]Szegezdi E, Logue SE, Gorman AM, Samali A: Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006, 7:880-885.
• [34]Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, Frutkin A, Dichek D, Giachelli CM: Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009, 104:733-741.
• [35]Canfield AE, Doherty MJ, Wood AC, Farrington C, Ashton B, Begum N, Harvey B, Poole A, Grant ME, Boot-Handford RP: Role of pericytes in vascular calcification: a review. Z Kardiol 2000, 2:20-27.
• [36]Collett GD, Canfield AE: Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 2005, 96:930-938.
• [37]Mungrue IN, Zhao P, Yao Y, Meng H, Rau C, Havel JV, Gorgels TG, Bergen AA, MacLellan WR, Drake TA, Boström KI, Lusis AJ: Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model. Arterioscler Thromb Vasc Biol 2011, 31:2806-2812.
• [38]Sowa AK, Kaiser FJ, Eckhold J, Kessler T, Aherrahrou R, Wrobel S, Kaczmarek PM, Doehring L, Schunkert H, Erdmann J, Aherrahrou Z: Functional interaction of osteogenic transcription factors Runx2 and Vdr in transcriptional regulation of Opn during soft tissue calcification. Am J Pathol 2013, 183:60-68.
• [39]Klement JF, Matsuzaki Y, Jiang Q-J, Terlizzi J, Choi HY, Fujimoto N, Li K, Pulkkinen L, Birk D, Sundberg JP, Uitto J: Targeted ablation of the Abcc6 gene results in ectopic mineralization of connective tissues. J Mol Cell Biol 2005, 25:8299-8310.
• [40]Borrás T, Comes N: Evidence for a calcification process in the trabecular meshwork. Exp Eye Res 2009, 88:738-746.
• [41]Demer LL, Tintut Y: Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008, 117:2938-2948.
• [42]Floege J, Ketteler M: Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 2004, 19:59-66.
• [43]LaRusso J, Li Q, Uitto J: Pseudoxanthoma elasticum, the paradigm of heritable ectopic mineralization disorders - can diet help? J Dtsch Dermatol Ges 2011, 9:586-593.
• [44]Le Saux O, Bunda S, Van Wart CM, Douet V, Got L, Martin L, Hinek A: Serum factors from Pseudoxanthoma Elasticum patients alter elastic fibre formation in vitro. J Invest Dermatol 2006, 126:1497-1505.
• [45]Uitto J, Váradi A, Bercovitch L, Terry PF, Terry SF: Pseudoxanthoma elasticum: progress in research toward treatment: summary of the, PXE international research meeting. J Invest Dermatol 2012, 2013(133):1444-1449.
• [46]Lefthériotis G, Abraham P, Le Corre Y, Le Saux O, Henrion D, Ducluzeau PH, Prunier F, Martin L: Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum. J Vasc Surg 2011, 54:1390-1394.
• [47]Massagué J, Wotton D: Transcriptional control by the TGF-beta/Smad signalling system. EMBO J 2000, 19:1745-1754.
• [48]Moustakas A, Souchelnytskyi S, Heldin CH: Smad regulation in TGF-beta signal transduction. J Cell Sci 2001, 114:4359-4369.
• [49]Johnson RC, Leopold JA, Loscalzo J: Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006, 99:1044-1059.
• [50]Shao JS, Cai J, Towler DA: Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006, 26:1423-1430.
• [51]Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993, 91:1800-1809.
• [52]Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S, Olsen BR: Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 2001, 106:97-106.
• [53]Rusanescu G, Weissleder R, Aikawa E: Notch signalling in cardiovascular disease and calcification. Curr Cardiol Rev 2008, 4:148-156.
• [54]Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
• [55]Komori T, Nomura S, Yamaguchi A, Sasaki K, Dequchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
• [56]Otto F, Thomell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
• [57]Lian JB, Javed A, Zaidi SK, Lenger C, Montecino M, van Wijnen AJ, Stein JL, Stein GS: Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 2004, 14:1-41.
• [58]Dai J, Rabie ABM: VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 2007, 86:937-950.
• [59]Zarbock R, Hendig D, Szliska C, Kleesiek K, Gotting C: Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum. Hum Mol Genet 2009, 18:3344-3351.
• [60]Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005, 115:1210-1220.
• [61]Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, Bland R, Zehnder D: Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 2007, 293:946-955.
• [62]Smajilovic S, Hansen JL, Christoffersen TE, Lewin E, Sheikh SP, Terwilliger EF, Brown EM, Haunso S, Tfelt-Hansen J: Extracellular calcium sensing in rat aortic vascular smooth muscle cells. Biochem Biophys Res Commun 2006, 348:1215-1223.
• [63]Barron F, Woods C, Kuhn K, Bishop J, Howard MJ, Clouthier DE: Downregulation of Dlx5 and Dlx6 expression by Hand2 is essential for initiation of tongue morphogenesis. Development 2011, 138:2249-2259.
• [64]Qadir AS, Woo KM, Ryoo HM, Baek JH: Insulin suppresses distal-less homeobox 5 expression through the up-regulation of microRNA-124 in 3 T3-L1 cells. Exp Cell Res 2013, 319:2125-2134.
• [65]Dolmans GH, Werker PM, Hennies HC, Furniss D, Festen EA, Franke L, Becker K, van der Vlies P, Wolffenbuttel BH, Tinschert S, Toliat MR, Nothnagel M, Franke A, Klopp N, Wichmann HE, Nürnberg P, Giele H, Ophoff RA, Wijmenga C, Dutch Dupuytren Study Group; German Dupuytren Study Group; LifeLines Cohort Study; BSSH-GODD Consortium: Wnt signalling and Dupuytren’s disease. N Engl J Med 2011, 365:307-317.
• [66]Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
• [67]Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM: BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003, 309:689-694.
• [68]Niger C, Lima F, Yoo DJ, Gupta RR, Buo AM, Hebert C, Stains JP: The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter. Bone 2011, 49:683-692.
• [69]Cunha SI, Pietras K: ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 2011, 117:6999-7006.
• [70]van Meeteren LA, ten Dijke P: Regulation of endothelial cell plasticity by TGF-β. Cell Tissue Res 2012, 347:177-186.
• [71]Simionescu A, Philips K, Vyavahare N: Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 2005, 334:524-532.
• [72]Jeziorska M: Transforming growth factor-betas and CD105 expression in calcification and bone formation in human atherosclerotic lesions. Z Kardiol 2001, 90:23-26.
• [73]Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA: Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004, 95:253-260.
• [74]Jiang Q, Matsuzaki Y, Li K, Uitto J: Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. J Invest Dermatol 2006, 126:325-335.
• [75]Xue W, Comes N, Borrás T: Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors. Invest Ophthalmol Vis Sci 2007, 48:3184-3194.
• [76]Ogata N, Yamamoto C, Miyashiro M, Yamada H, Matsushima M, Uyama M: Expression of transforming growth factor-beta mRNA in experimental choroidal neovascularization. Curr Eye Res 1997, 16:9-18.
• [77]Diekmann U, Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C: Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. J Mol Med (Berl) 2009, 87:965-970.
• [78]Kim ES, Kim MS, Moon A: TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signalling in MCF10A human breast epithelial cells. Int J Oncol 2004, 25:1375-1382.
• [79]Eldred JA, Hodgkinson LM, Dawes LJ, Reddan JR, Edwards DR, Wormstone IM: MMP2 activity is critical for TGFβ2-induced matrix contraction–implications for fibrosis. Invest Ophthalmol Vis Sci 2012, 53:4085-4098.
• [80]Kang JS, Liu C, Derynck R: New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 2009, 19:385.
• [81]Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, Kempers MJ, Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid BM, Yang MH, Bongers EM, Timmermans J, Braverman AC, Canham N, Mortier GR, Brunner HG, Byers PH, Van Eyk J, Van Laer L, Dietz HC, Loeys BL: Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 2012, 44:922-927.
• [82]Pasquali-Ronchetti I, Garcia-Fernandez MI, Boraldi F, Quaglino D, Gheduzzi D, De Vincenzi PC, Tiozzo R, Bergamini S, Ceccarelli D, Muscatello U: Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations. J Pathol 2006, 208:54-61.
• [83]Chikazu D, Li X, Kawaguchi H, Sakuma Y, Voznesensky OS, Adams DJ, Xu M, Hoshio K, Katavic V, Herschman HR, Raisz LG, Pilbeam CC: Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 2002, 17:1430-1440.
• [84]Gorenne I, Bennett MR: Oxidative stress in vascular disease: aging and age-related disorders. In Aging and Age-Related Disorders. Edited by Bondy S, Maiese K. New York: Humana Press; 2010:211-235.
• [85]Jin GF, Hurst JS, Godley BF: Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium. Curr Eye Res 2011, 23:11-19.
• [86]Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, McDonald JM, Chen Y: Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signalling. J Biol Chem 2008, 283:15319-15327.
• [87]Al-Aly Z: Phosphate, oxidative stress, and nuclear factor-κB activation in vascular calcification. Kidney Int 2011, 79:1044-1047.
• [88]Tian XY, Yung LH, Wong WT, Liu J, Leung FP, Liu L, Chen Y, Kong SK, Kwan KM, Ng SM, Lai PB, Yung LM, Yao X, Huang Y: Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway. J Mol Cell Cardiol 2012, 52:237-244.
• [89]Kyriakakis E, Philippova M, Joshi MB, Pfaff D, Bochkov V, Afonyushkin T, Erne P, Resink TJ: T-cadherin attenuates the PERK branch of the unfolded protein response and protects vascular endothelial cells from endoplasmic reticulum stress-induced apoptosis. Cell Signal 2010, 22:1308-1316.
• [90]Duan X, Zhou Y, Teng X, Tang C, Qi Y: Endoplasmic reticulum stress-mediated apoptosis is activated in vascular calcification. Biochem Biophys Res Commun 2009, 387:694-699.
• [91]Masuda M, Ting TC, Levi M, Saunders SJ, Miyazaki-Anzai S, Miyazaki M: Activating transcription factor 4 regulates stearate-induced vascular calcification. J Lipid Res 2012, 53:1543-1552.
• [92]Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA: Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun 2011, 413:436-441.
• [93]Saito A, Ochiai K, Kondo S, Tsumagari K, Murakami T, Cavener DR, Imaizumi K: Endoplasmic reticulum stress response mediated by the PERK-eIF2 (alpha)-ATF4 pathway is involved in osteoblast differentiation induced by BMP2. J Biol Chem 2011, 286:4809-4818.
• [94]Pasquali-Ronchetti I, Volpin D, Baccarani-Contri M, Castellani I, Peserico A: Pseudoxanthoma elasticum. Biochemical and ultrastructural studies. Dermatologica 1981, 163:307-325.
• [95]Baccarani-Contri M, Bacchelli B, Boraldi F, Quaglino D, Taparelli F, Carnevali E, Francomano MA, Seidenari S, Bettoli V, De Sanctis V, Pasquali-Ronchetti I: Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia. J Am Acad Dermatol 2001, 44:33-39.
• [96]Boraldi F, Annovi G, Guerra D, Paolinelli Devincenzi C, Garcia-Fernandez MI, Panico F, De Santis G, Tiozzo R, Ronchetti I, Quaglino D: Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in the pathogenesis of pseudoxanthoma elasticum. Proteomics Clin Appl 2009, 3:1084-1098.
• [97]Cai Z, Li F, Gong W, Liu W, Duan Q, Chen C, Ni L, Xia Y, Cianflone K, Dong N, Wang DW: Endoplasmic Reticulum Stress Participates in Aortic Valve Calcification in Hypercholesterolemic Animals. Arterioscler Thromb Vasc Biol 2013. In press
• [98]Haÿ E, Lemonnier J, Fromigué O, Marie PJ: Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signalling pathway. J Biol Chem 2001, 276:29028-29036.
• [99]Ghali O, Chauveau C, Hardouin P, Broux O, Devedjian JC: TNF-alpha’s effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression. J Bone Miner Res 2010, 25:1616-1626.
• [100]Ossareh S: Vascular calcification in chronic kidney disease: mechanisms and clinical implications. Iran J Kidney Dis 2011, 5:285-299.
• [101]Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004, 15:2857-2867.
• [102]Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX: Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003, 285:740-754.
• [103]Lagna G, Nguyen PH, Ni W, Hata A: BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006, 291:1059-1067.
• [104]Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998, 281:1312-1316.
• [105]Cryns V, Yuan J: Proteases to die for. Genes Dev 1998, 12:1551-1570.
• [106]Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES: Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002, 277:13430-13437.
• [107]Ruchko M, Gorodnya O, Le Doux SP, Alexeyev MF, Al-Mehdi AB, Gillespie MN: Mitochondrial DNA damage triggers mitochondrial dysfunction and apoptosis in oxidant-challenged lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 2005, 288:530-535.
• [108]Bao LL, Yang JS, Xiao J, Guo ZT: Pseudoxanthoma elasticum. A report of 5 cases in one family. Chin Med J (Engl) 1991, 104:237-243.
• [109]Martin LJ, Lau E, Singh H, Vergnes L, Tarling EJ, Mehrabian M, Mungrue I, Xiao S, Shih D, Castellani L, Ping P, Reue K, Stefani E, Drake TA, Boström K, Lusis AJ: ABCC6 localizes to the mitochondria-associated membrane. Circ Res 2012, 111:516-520.
• [110]Neldner K, Struk B: Connective Tissue and Its Heritable Disorders. New York, NY, USA: Wiley-Liss; 2002:561-583.
• [111]Vanakker OM, Leroy BP, Coucke P, Bercovitch LG, Uitto J, Viljoen D, Terry SF, Van Acker P, Loeys B, De Paepe A: Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart. Hum Mutat 2008, 29:1-13.
• [112]Verbraak FD: Antivascular endothelial growth factor treatment in pseudoxanthoma elasticum patients. Dev Ophthalmol 2010, 46:96-106.
• [113]ten Dijke P, Hill CS: New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004, 29:265-273.
• [114]Sanvitale CE, Kerr G, Chaikuad A, Ramel MC, Mohedas AH, Reichert S, Wang Y, Triffitt JT, Cuny GD, Yu PB, Hill CS, Bullock AN: A new class of small molecule inhibitor of BMP signaling. PLoS One 2013, 8:e6272.
• [115]Mohedas AH, Xing X, Armstrong KA, Bullock AN, Cuny GD, Yu PB: Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor. ACS Chem Biol 2013, 8:1291-1302.